| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 10/07/2004 | US20040198747 Sodium channel blockers |
| 10/07/2004 | US20040198746 Sodium channel blockers |
| 10/07/2004 | US20040198745 Sodium channel blockers |
| 10/07/2004 | US20040198744 Methods of using phenolic guanidine sodium channel blockers |
| 10/07/2004 | US20040198743 Administering synergistic mixture |
| 10/07/2004 | US20040198737 Azaindoles |
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 10/07/2004 | US20040198718 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 10/07/2004 | US20040198701 EP4 receptor agonist, compositions and methods thereof |
| 10/07/2004 | US20040198696 Agent and food for inhibiting IgE antibody |
| 10/07/2004 | US20040198682 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA) |
| 10/07/2004 | US20040198677 macrolide and steroidal or non-steroidal substructures connected by an alkyl linker; esterification or amidation to couple; antiarthritic, antiasthmatic agents, nasal, gastrointestinal, dermatological and opthalmic disorders; veterinary or human therapy |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040198644 Integrin inhibitors for the treatment of eye diseases |
| 10/07/2004 | US20040197902 Transgenic mammalian endothelial progenitor cells for use in the treatment of vision defects; gene therapy and neovascularization |
| 10/07/2004 | US20040197340 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 10/07/2004 | US20040197307 Mixture of human interferons |
| 10/07/2004 | CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 10/06/2004 | EP1464673A2 Polyanhydrides with biologically active degradation products |
| 10/06/2004 | EP1464646A1 Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp |
| 10/06/2004 | EP1464330A1 Use of a composition containing oligosaccharides in combination with a saponine or a basic aminoacid, for topical administration or for inhalation |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463735A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 10/06/2004 | EP1463725A1 Process and intermediates for pyridazinone antidiabetic agents |
| 10/06/2004 | EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463563A1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 10/06/2004 | EP1463531A1 Methods for inhibiting ocular processes |
| 10/06/2004 | EP1463514A2 Utilization of rutins and aescins in the treatment of ocular circulatory disturbances |
| 10/06/2004 | EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof |
| 10/06/2004 | EP1463503A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 10/06/2004 | EP1463494A1 Use of polycyclic phenolic compounds for the treatment of opthalmic diseases |
| 10/06/2004 | EP1463408A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 10/06/2004 | EP1185256B1 Utilization of a highly fluorinated oligomeric alkan in ophthalmology |
| 10/06/2004 | EP1181934B1 1,4-dihydropyridine derivatives as inhibitors for optic hypofunction caused by optic nerve cell injury induced by factors other than optic circulatory disorder |
| 10/06/2004 | EP1140080B1 Use of riluzole for treating acoustic traumas |
| 10/06/2004 | EP1133284B1 A process for the preparation of crystalline particles |
| 10/06/2004 | EP1018878B1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
| 10/06/2004 | CN1535163A Delivery system for nucleic acids |
| 10/06/2004 | CN1535156A Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 10/06/2004 | CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl} |
| 10/06/2004 | CN1535149A Topical application of thiazolyl amides |
| 10/06/2004 | CN1535138A Ophthalmic composition containing N-acetyl-cysteine for treatment of dry-eye syndrome |
| 10/06/2004 | CN1535116A Nutritional supplement to treat macular degeneration |
| 10/06/2004 | CN1534028A New azadicyclo salt kind compound and its use in treating protein aging disease |
| 10/06/2004 | CN1169824C Polytype gene of MXA protein and application thereof |
| 10/06/2004 | CN1169808C 'Beta'-carboline compound |
| 10/06/2004 | CN1169805C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 10/06/2004 | CN1169573C Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides |
| 10/06/2004 | CN1169528C Prostaglandin derivatives devoid of side-effects for treatment of glaucoma |
| 10/05/2004 | US6800761 Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 10/05/2004 | US6800653 Anticancer agents |
| 10/05/2004 | US6800633 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 10/05/2004 | US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc. |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent |
| 10/05/2004 | US6800446 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 09/30/2004 | WO2004083382A2 Compositions and methods for treating hyperimmune response in the eye |
| 09/30/2004 | WO2004083257A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 09/30/2004 | WO2004082673A1 Liquid ophthalmic composition |
| 09/30/2004 | WO2004082670A1 Methadone-containing compositions for parenteral administration and use thereof |
| 09/30/2004 | WO2004082625A2 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | WO2004082582A2 Use of diazoxide in the treatment of ischemia retinae |
| 09/30/2004 | WO2004064912A8 An otorhinological delivery device |
| 09/30/2004 | WO2003087333A8 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | US20040192916 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents |
| 09/30/2004 | US20040192914 Compounds and methods |
| 09/30/2004 | US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents |
| 09/30/2004 | US20040192763 Central nervous system disorders; antidepressants; neurodegenative diseases; restless leg syndrome; antiepileptic agents; headaches; hearing disorders |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/30/2004 | US20040192756 Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the opthalmic field |
| 09/30/2004 | US20040192735 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192722 Selective iGluR5 receptor antagonists |
| 09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 09/30/2004 | US20040192699 Vision defects |
| 09/30/2004 | US20040192691 Analgesics; antiischemic agents; amyotrophic lateral sclerosis; anticonvulsants; antidepressants; local anesthetics; antiarrhythmia agents; neuropathic pain |
| 09/30/2004 | US20040192670 For inhibiting bone resorption, treating/preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, aniogenesis, atherosclerosis, arthritis, tumor growth and metastasis |
| 09/30/2004 | US20040192628 gene expression inhibition of the kinase to prevent neovascularization, treat cancer |
| 09/30/2004 | US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/30/2004 | US20040191284 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | US20040191177 Solutions with glycerol or sorbitol and adjuvants with active material |
| 09/30/2004 | CA2519300A1 Self-emulsifying compositions, methods of use and preparation |
| 09/29/2004 | EP1462455A1 Novel peptides and medicinal uses thereof |
| 09/29/2004 | EP1462112A1 Remedies for dry eye and diseases associated with dry eye |
| 09/29/2004 | EP1462100A1 Composition comprising formoterol and a glucosorticosteroid |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461336A2 1-alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 09/29/2004 | EP1461333A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461323A2 Compounds for the treatment of metabolic disorders |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461318A2 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/29/2004 | EP1461306A1 Quaternary ammonium compounds and their use as antimuscarinic agents |
| 09/29/2004 | EP1461090A2 Composition and method for treatment of otitis media |
| 09/29/2004 | EP1461070A2 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 09/29/2004 | EP1461054A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |